
CING vs GSK
$CING vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
CING vs GSK: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.2%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only CING beat the market over the past year, by 24.6%, while GSK trailed the S&P 500 at +3.2% by 1.5%.
- ·CING is within 2% of resistance at $4.70, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
CING vs GSK: the quick read
- ·GSK is the larger company by market cap ($95.73B vs $67M).
- ·CING has been more active on our scanner (131 vs 77 alerts in 30 days).
- ·CING has the smaller float (10.4M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: CING is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 131 and 77 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 1419x the market cap of CING, so the same dollar of news moves CING far harder.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·GSK pays a dividend and CING does not, which usually means one is being held for income and the other for the move.
- ·CING is the one in play today, trading about 4.5x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching CING or GSK? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing CING and GSK on TheDesperateTrader.
- Is CING or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($95.73B vs $67M). CING has been more active on our scanner (131 vs 77 alerts in 30 days). CING has the smaller float (10.4M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between CING and GSK?
- The differences that matter: GSK is roughly 1419x the size of the other by market cap ($67M vs $95.73B); they trade at very different share prices ($4.61 vs $47.96); CING sits at 17% of its 52-week range against 14% for GSK; only GSK pays a dividend; our scanner flagged CING 131 times in the last 30 days against 77 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of CING and GSK is more active right now?
- Right now CING is at about 4.5x its normal volume and GSK is at about 0.6x, so CING is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is CING or GSK in the stronger trend?
- CING is below its 50-day average of $4.81 and below its 200-day average of $5.35; GSK is below its 50-day average of $49.31 and below its 200-day average of $52.25. CING leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading CING or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.